Influence of Maternal Characteristics during Pregnancy on the Infant Early Life Immune Responses in a High HIV Burdened Setting in Harare, Zimbabwe

Agness Farai Nhidza, Thajasvarie Naicker, Babill Stray-Pedersen, Felicity Gumbo, Tawanda Chisango, Edson Sibanda, Gwendoline Kandawasvika, Aziah Ismail, Tsitsi Bandason, Curtis Makaza, Kerina Duri, Takafira Mduluza

Abstract

This study aimed at investigating the maternal characteristics that in turn influence the immunological status of infants in asymptomatic enteric pathogen carriers in mother baby pairs (MBPs) in a high HIV burdened population in Harare, Zimbabwe. BIOPLEX immunoassay was used to analyse serum samples from 39 MBPs for 27 cytokines and 6 immunoglobulins. The MBP were purposively selected based on HIV infection and Entamoeba histolytica carriage. Logistic regression was used to identify any link between maternal demographic and clinical data with infant cytokine and immunoglobulin levels. Maternal E. histolytica carriers were more likely to have infants with low levels of IL-12p70, FGF-basic, GM-CSF and TNF-α cytokines (OR: 0.14; 95% CI: 0.03-0.79) and high levels of IgA immunoglobulin (OR: 8.1; 95% CI: 1.45-45.06). HIV infected mothers were more likely to have infants with low levels of IgG2 (OR:  0.24; 95% CI: 0.06-1.00) and IgA (OR: 0.22; 95% CI: 0.05-0.90) immunoglobulins. Notably, it was highly likely to deliver infants with low IgG4 levels (OR:  0.24; 95% CI: 0.06-1.02) for maternal mean age above 30.38 years (Standard deviation 6.09) though not significant (p=0.05). MaternalE. histolytica asymptomatic carriage, and HIV-infection status result in low levels of pro-inflammatory cytokines IL-12p70, FGF-basic, GM-CSF and TNF-α and immunoglobulins IgG2, IgG4 and IgA on their infants.(Afr J Reprod Health 2018; 22[3]:43-50).

Full Text:

PDF

References

Afran L, Garcia Knight M, Nduati E, Urban BC,

Heyderman RS and Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system?: HEU children: a vulnerable immune system? Clin Exp Immunol. 2014 Apr;176(1):11–22.

Omoni AO, Ntozini R, Evans C, Prendergast AJ, Moulton

LH, Christian PS and Humphrey JH. Child Growth According to Maternal and Child HIV Status in Zimbabwe: Pediatr Infect Dis J. 2017 Sep;36(9):869–76.

Slogrove AL, Goetghebuer T, Cotton MF, Singer J and

Bettinger JA. Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children. Front Immunol [Internet]. 2016 May 6 [cited 2016 Nov 30];7. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2016.00164/abstract

Velilla P, Montoya C, Hoyos A, Moreno M, Chougnet C and

Rugeles M. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns’ dendritic cells. Clin Immunol. 2008;126(3):243–50.

Rich KC, Siegel JN, Jennings C, Rydman RJ and Landay

AL. Function and Phenotype of Immature CD4ϩ Lymphocytes in Healthy Infants and Early Lymphocyte Activation in Uninfected Infants of Human Immunodeficiency Virus-Infected Mothers. 1997;4:4.

Kuller LH, Tracy R, Belloso W, Wit SD, Drummond F,

Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI and Neaton JD. INSIGHT SMART Study Group. Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. Deeks S, editor. PLoS Med. 2008 Oct 21;5(10):e203.

Hazra R, Cohen R, Gonin R, Monteiro J, Hofer C, Negra M

and Ruz NP. NISDI Pediatric Study Group. Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American children. AIDS. 2012;26(2):235–40.

Viganò A, Cerini C, Pattarino. G, Fasan S and Zuccotti G.

Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients. Expert Opin Drug Saf. 2010;9(3):435–45.

Miller T, Borkowsky W, DiMeglio L, Dooley L, Geffner

M, Hazra R, McFarland EJ, Mendez, AJ, Patel K, Siberry GK, Van Dyke RB, Worrell CJ and Jacobson DL. Pediatric HIV/AIDS Cohort Study (PHACS). Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children: Vascular dysfunction in paediatric HIV infection. HIV Med. 2012 May;13(5):264–75.

Melvin A, Kang M, Livingston E, Cohn S, Stocker V, Ross

AC, Watts H and McComsey GA. Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy. Antivir Ther. 2008;13(3):349–55.

Elahi S, Buchanan R, Babiuk L and Gerdts V. Maternal

Immunity Provides Protection against Pertussis in Newborn Piglets. Infect Immun. 2006 May 1;74(5):2619–2627.

Bernin H, Marggraff C, Jacobs T, Brattig N, An LV,

Blessmann J and Lotter H. Immune markers characteristic for asymptomatically infected and diseased Entamoeba histolytica individuals and their relation to sex. BMC Infect Dis [Internet]. 2014 Dec [cited 2018 Jul 24];14(1). Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-014-0621-1

Van Egmond M, Hanneke van Vuuren A and Van de Winkel

J. The human Fc receptor for IgA (Fc alpha RI, CD89) on transgenic peritoneal macrophages triggers - phagocytosis and tumor cell lysis. Immunol Lett. 1999;68:83.

Peterson KM, Shu J, Duggal P, Haque, R, Mondal D and

Petri WJ. Association between TNF-α and Entamoeba histolytica Diarrhea. Am J Trop Med Hyg. 2010;82(4):620–5.

Zhang J-M and An J. Cytokines, Inflammation, and Pain.

Int Anesthesiol Clin. 2007;45(2):27–37.

Picard C, Baud O, Fieschi and Casanova J. Diagnosis and Management of Inheritable Disorders of Interferon-γ–mediated Immunity. Immunol Allergy Clin North Am. 2000;20(1).

Ushach I and Zlotnik A. Biological role of granulocyte

macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J Leukoc Biol. 2016 Sep 1;100(3):481–9.

Burgess SL, Saleh M, Cowardin CA, Buonomo E, Noor Z,

Watanabe K, Abhyankar M, Lajoie S, Wills-Karp M and Petri WA Jr. Role of Serum Amyloid A, Granulocyte-Macrophage Colony-Stimulating Factor, and Bone Marrow Granulocyte-Monocyte Precursor Expansion in Segmented Filamentous Bacterium-Mediated Protection from Entamoeba histolytica. Young VB, editor. Infect Immun. 2016 Oct;84(10):2824–32.

Nunes QM, Li Y, Sun C, Kinnunen TK and Fernig DG.

Fibroblast growth factors as tissue repair and regeneration therapeutics.PeerJ. 2016 Jan 12;4:e1535.

Yates CC, Hebda P and Wells A. Skin Wound Healing and

Scarring: Fetal Wounds and Regenerative Restitution: Scarless and Scarring Healing. Birth Defects Res Part C Embryo Today Rev. 2012 Dec;96(4):325–33.

Sehgal D, Bhattacharya A and Bhattacharya S.

Pathogenesis of infection by Entamoeba histolytica.J Biosci. 1996 May;21(3):423–32.

Nakada-Tsukui K and Nozaki T. Immune Response of

Amebiasis and Immune Evasion by Entamoeba histolytica. Front Immunol [Internet]. 2016 May 12 [cited 2016 Nov 30];7. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2016.00175/abstract

Abu-Raya B, Smolen KK, Willems F, Kollmann TR and

Marchant A. Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns. Front Immunol [Internet]. 2016 Aug 31 [cited 2016 Nov 30];7. Available from: http://journal.frontiersin.org/Article/10.3389/fimmu.2016.00338/abstract

Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA and

Carneiro-Sampaio M. IgG Placental Transfer in Healthy and Pathological Pregnancies. Clin Dev Immunol. 2012;2012:1–13.

Simon A, Hollander G and McMichael A. Evolution of the

immune system in humans from infancy to old age. Proc R Soc B Biol Sci. 2015 Dec 22;282(1821).

Refbacks

  • There are currently no refbacks.